9 Results for "

IRE1α RNase activity

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "IRE1α RNase activity" in MCE Product Catalog:

14
14 Publications Verification
Cat. No.: HY-114368
CAS No.: 1630086-20-2
Purity:  98.90%
Synonyms: AMG-18
Target:  

IRE1

Research Areas:  

Inflammation/Immunology

Kira8 (AMG-18) is a mono-selective IRE1α inhibitor that allosterically attenuates IRE1α RNase activity with an IC50 of 5.9 nM .
loading...
    loading...
14
14 Publications Verification
Cat. No.: HY-114368A
CAS No.: 2250019-92-0
Synonyms: AMG-18 Hydrochloride
Target:  

IRE1

Research Areas:  

Inflammation/Immunology

Kira8 Hydrochloride (AMG-18 Hydrochloride) is a mono-selective IRE1α inhibitor that allosterically attenuates IRE1α RNase activity with an IC50 of 5.9 nM .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-U00459
CAS No.: 2121989-91-9
Synonyms: GSK163
Target:  

IRE1

Research Areas:  

Cancer

GSK2850163 is a novel inhibitor of inositol-requiring enzyme-1 alpha (IRE1α) which can inhibit IRE1α kinase activity and RNase activity with IC50s of 20 and 200 nM, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-136735
CAS No.: 2328097-41-0
Purity:  98.94%
Target:  

IRE1

Research Areas:  

Neurological Disease Cancer

IRE1α kinase-IN-1 is a highly selective IRE1α (ERN1) inhibitor, with an IC50 of 77 nM. IRE1α kinase-IN-1 displays 100-fold selectivity for IRE1α over the IRE1β isoform. IRE1α kinase-IN-1 inhibits ER stress-induced IRE1α oligomerization and autophosphorylation, and also inhibits IRE1α RNase activity (IC50=80 nM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-U00460
Target:  

IRE1

Research Areas:  

Cancer

3,6-DMAD hydrochloride, an acridine derivative, is a potent IRE1α-XBP1s pathway inhibitor. 3,6-DMAD hydrochloride promotes IL-6 secretion via the IRE1α-XBP1s pathway. 3,6-DMAD hydrochloride inhibits IRE1α oligomerization and endoribonuclease (RNase) activity. 3,6-DMAD hydrochloride can be used for research of cancer .
loading...
    loading...
Cat. No.: HY-124646
CAS No.: 1937235-76-1
Purity:  98.33%
Target:  

IRE1

Research Areas:  

Inflammation/Immunology

KIRA-7, an imidazopyrazine compound, binds the IRE1α kinase (IC50 of 110 nM) to allosterically inhibit its RNase activity. KIRA-7 has an anti-fibrotic effect .
loading...
    loading...
Cat. No.: HY-145425
CAS No.: 2771006-54-1
Target:  

IRE1 Apoptosis FGFR

Research Areas:  

Inflammation/Immunology

PAIR2 is a highly selective inhibitor targeting the kinase domain of human IRE1α, with a Ki value of 8.8 nM against human IRE1α. PAIR2 fully occupies the ATP-binding site of the IRE1α kinase domain, partially antagonizes the ribonuclease activity of IRE1α, specifically inhibits regulated IRE1α-dependent decay (RIDD) and its mediated substrate cleavage, while preserving the splicing function of Xbp1 mRNA. PAIR2 also promotes the differentiation of B cells into plasma cells, blocks IRE1α-induced cell apoptosis, and restores the expression of Fgfr2 mRNA in AT2 cells. PAIR2 effectively reaches a steady-state concentration in the lung tissues of Mus musculus, and serves as an important tool for investigating the function of the IRE1α signaling pathway in diseases such as pulmonary fibrosis .
loading...
    loading...
Cat. No.: HY-U00459B
CAS No.: 2319838-09-8
Synonyms: GSK163 hydrochloride
Target:  

IRE1

Research Areas:  

Cancer

GSK2850163 hydrochloride is a novel inhibitor of inositol-requiring enzyme-1 alpha (IRE1α) which can inhibit IRE1α kinase activity and RNase activity with IC50s of 20 and 200 nM, respectively.
loading...
    loading...
Cat. No.: HY-U00460B
CAS No.: 2226511-77-7
Target:  

IRE1

Research Areas:  

Cancer

3,6-DMAD dihydrochloride, an acridine derivative, is a potent IRE1α-XBP1s pathway inhibitor. 3,6-DMAD dihydrochloride promotes IL-6 secretion via the IRE1α-XBP1s pathway. 3,6-DMAD dihydrochloride inhibits IRE1α oligomerization and endoribonuclease (RNase) activity. 3,6-DMAD dihydrochloride can be used for research of cancer .
loading...
    loading...